Your browser doesn't support javascript.
loading
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Simmons, Kristen; Thomas, Jane V; Ludford, Kaysia; Willis, Jason A; Higbie, Victoria S; Raghav, Kanwal P S; Johnson, Benny; Dasari, Arvind; Kee, Bryan K; Parseghian, Christine M; Lee, Michael S; Le, Phat H; Morelli, Maria P; Shen, John Paul; Bent, Alisha; Vilar, Eduardo; Wolff, Robert A; Kopetz, Scott; Overman, Michael J; Morris, Van Karlyle.
Afiliación
  • Simmons K; Department of Hematology/Oncology, Baylor College of Medicine, Houston, Texas.
  • Thomas JV; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Ludford K; Department of General Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Willis JA; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Higbie VS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Raghav KPS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Johnson B; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Kee BK; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Parseghian CM; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Le PH; Department of General Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Morelli MP; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Bent A; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Vilar E; Clinical Cancer Prevention, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
  • Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
Cancer Res Commun ; 3(12): 2510-2517, 2023 12 11.
Article en En | MEDLINE | ID: mdl-38085001
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article